	US 11,918,615 B2
	Anti-inflammatory botanical extract
Jatinder Rana, Grand Rapids, MI (US); and Kylie Mitchell, Pennington, NJ (US)
Assigned to Innophos, LLC, Cranbury, NJ (US)
Filed by Innophos, LLC, Cranbury, NJ (US)
Filed on Sep. 7, 2021, as Appl. No. 17/467,830.
Application 17/467,830 is a division of application No. 16/561,596, filed on Sep. 5, 2019, granted, now 11,141,446.
Claims priority of provisional application 62/728,125, filed on Sep. 7, 2018.
Prior Publication US 2022/0031788 A1, Feb. 3, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 36/45 (2006.01); A61K 9/00 (2006.01); A61K 31/353 (2006.01); A61P 29/00 (2006.01)

CPC A61K 36/45 (2013.01) [A61K 9/0014 (2013.01); A61K 9/0053 (2013.01); A61K 31/353 (2013.01); A61P 29/00 (2018.01)]

7 Claims

1. A composition comprising:

a botanical extract of a leaf of Vaccinium macrocarpon,

wherein the botanical extract is present in an amount of about 50.0 μg/mL to about 500.0 μg/mL,

wherein the botanical extract comprises at least isoquercetin and kaempferol and is free of anthocyanins,

wherein the extract is obtained by extracting dried ground cranberry leaf powder with a solvent of ethanol in water and evaporating the solvent,

a pharmaceutically acceptable carrier,

wherein the composition exhibits anti-inflammatory activity.